04:43 AM EDT, 03/12/2024 (MT Newswires) -- Belite Bio ( BLTE ) reported late Monday a Q4 net loss of $0.25 per ordinary share, compared with the $0.27 loss per share a year earlier.

Five analysts polled by Capital IQ expected a loss of $0.30 per share.

As expected, the company reported no revenue for the quarter ended Dec. 31, 2023.

As of the end of 2023, the company had a cash balance of $88.2 million.